A new study published in the journal Nature Metabolism indicates that anti-obesity drug liraglutide can restore associative learning impairments caused by obesity—which can hinder motivation—after just one dose.
From childhood learning disabilities to age-related dementia, new research provides evidence for treatment that can truly make a difference. This compelling video offers hope for
